发明名称 USE OF PEG-IFN-ALPHA AND RIVABIRIN FOR TREATMENT OF CHRONIC HEPATITIS C
摘要 PROBLEM TO BE SOLVED: To provide a kit for the treatment of chronic hepatitis C infection disease. SOLUTION: The kit effective for the treatment of hepatitis C contains rivabirin and PEG-IFN-αconjugate expressed by formula (R and R' are each methyl; X is NH; and n and n' are each independently 420 or 520) and is administered to a patient of chronic hepatitis C infection disease. COPYRIGHT: (C)2006,JPO&NCIPI
申请公布号 JP2006160759(A) 申请公布日期 2006.06.22
申请号 JP20060025756 申请日期 2006.02.02
申请人 F HOFFMANN LA ROCHE AG 发明人 ZAHM FRIEDERIKE
分类号 A61K38/21;A61K31/70;A61K31/7052;A61K31/7056;A61K47/48;A61P1/16;A61P31/12;A61P31/14;A61P43/00 主分类号 A61K38/21
代理机构 代理人
主权项
地址